Saturday 17 October 2026
Export ICLR’s income statement to Excel — free account
ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024. In the quarter to June 2026, revenue grew 1.20%, EPS fell 59.3%, free cash flow grew 109.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
170.18
4.95
−2.83%
Follow ICLR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
70.64 | 23.39 | 37.64 | 31.27 | 102.89 | 31.45 | 25.14 | 21.68 | 22.06 | 15.53 |
Piotroski F-Score |
6 | 7 | 8 | 7 | 3 | 5 | 5 | 7 | 6 | 7 |
Altman Z-Score |
2.01 | 2.41 | 2.71 | 1.88 | 1.87 | 5.95 | 6.65 | 6.72 | 5.93 | 5.06 |
P/S ratio |
1.73 | 2.11 | 2.84 | 2.04 | 3.79 | 3.68 | 3.31 | 2.69 | 3.52 | 2.48 |
P/FCF ratio |
16.58 | 15.46 | 22.60 | 37.48 | 28.26 | 19.55 | 25.63 | 31.75 | 18.31 | 19.06 |
Altman Z″-Score (non-manufacturers) |
2.10 | 2.57 | 2.32 | 1.89 | 1.50 | 5.06 | 4.75 | 5.72 | 5.13 | 4.99 |
Beneish M-Score |
(2.62) | (2.77) | (2.56) | (2.24) | (1.30) | (2.53) | (2.32) | (1.97) | (2.69) | (2.42) |
P/Operating CF |
61.03 | 51.13 | 52.38 | (265.60) | 71.71 | 52.74 | 69.00 | 114.89 | 58.52 | 31.71 |
P/B ratio |
1.55 | 1.83 | 2.49 | 1.86 | 2.58 | 5.57 | 5.60 | 5.16 | 5.20 | 4.37 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.16 | 13.13 | 12.86 | 17.69 | 15.15 |
EV/Sales |
2.07 | 2.46 | 3.26 | 2.60 | 4.65 | 3.52 | 3.26 | 2.79 | 3.72 | 2.74 |
EV/EBITDA |
20.64 | 13.27 | 17.15 | 14.76 | 36.72 | 21.50 | 17.39 | 16.47 | 16.35 | 12.30 |
EV/Operating CF |
16.45 | 15.69 | 22.78 | 35.77 | 30.71 | 17.32 | 22.14 | 26.94 | 17.06 | 17.61 |
EV/FCF |
19.77 | 18.04 | 25.92 | 47.84 | 34.63 | 18.66 | 25.24 | 32.86 | 19.31 | 21.08 |
Quick Ratio |
0.72 | 0.79 | 0.82 | 0.79 | 0.89 | 1.44 | 1.03 | 1.52 | 1.41 | 1.48 |
Current Ratio |
1.10 | 1.24 | 1.21 | 1.20 | 1.19 | 1.87 | 1.44 | 2.18 | 1.95 | 1.94 |
Net Debt/EBITDA |
3.34 | 1.90 | 2.20 | 3.20 | 6.75 | (1.03) | (0.27) | (0.24) | (0.03) | 0.24 |
Debt/Assets |
20.91% | 20.60% | 22.22% | 27.08% | 31.27% | 10.84% | 14.67% | 14.84% | 16.25% | 19.09% |
Debt/Equity |
0.37 | 0.36 | 0.41 | 0.55 | 0.67 | 0.20 | 0.26 | 0.26 | 0.29 | 0.37 |
Asset Turnover |
0.50 | 0.49 | 0.48 | 0.45 | 0.53 | 0.88 | 1.07 | 1.15 | 0.89 | 0.94 |
Operating CF/Net income |
4.52 | 1.74 | 1.90 | 1.11 | 5.41 | 1.71 | 1.10 | 0.83 | 1.36 | 0.99 |
Capex/Depreciation |
(0.45) | (0.34) | (0.24) | (0.25) | (0.30) | (0.62) | (0.55) | (0.73) | (0.73) | (0.72) |
Interest Coverage |
2.24 | 4.35 | 2.84 | 3.46 | 2.08 | 30.07 | 32.65 | 27.65 | 26.79 | 23.97 |
| 2.46% | 7.91% | 6.90% | 6.10% | 3.09% | 18.95% | 24.83% | 25.35% | 26.35% | 30.70% | |
| 1.39% | 4.40% | 3.58% | 2.92% | 1.47% | 10.48% | 14.22% | 14.34% | 14.17% | 14.80% | |
ROIC |
2.32% | 5.23% | 4.73% | 3.86% | 1.86% | 17.72% | 17.89% | 18.70% | 17.93% | 18.86% |
Return on Tangible Assets |
32.71% | 72.28% | 64.66% | 56.85% | 19.18% | 28.81% | 56.77% | 36.74% | 40.33% | 42.80% |
Average Days of Receivables |
73.10 | 69.34 | 87.53 | 86.94 | 96.55 | 101.62 | 76.85 | 66.75 | 90.85 | 102.83 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.45% | 8.89% | 9.46% | 10.06% | 10.68% | 12.24% | 12.00% | 12.55% | 18.41% | 19.55% |
Intangible Assets out of Total Assets |
0.74 | 0.76 | 0.76 | 0.77 | 0.79 | 0.29 | 0.33 | 0.34 | 0.39 | 0.37 |
Share Based Compensation of Revenue |
1.24% | 0.56% | 0.69% | 0.91% | 2.44% | 0.94% | 0.96% | 1.22% | 1.74% | 2.42% |
Graham Net Nets |
(0.25) | (0.23) | (0.19) | (0.35) | (0.31) | 0.05 | 0.04 | 0.05 | 0.02 | 0.02 |
Graham Number |
82.48 | 151.96 | 137.45 | 120.48 | 90.23 | 69.88 | 68.87 | 57.93 | 50.69 | 43.03 |
Earnings Yield |
1.42% | 4.28% | 2.66% | 3.20% | 0.97% | 3.18% | 3.98% | 4.61% | 4.53% | 6.44% |
Free Cash Flow Yield |
6.03% | 6.47% | 4.43% | 2.67% | 3.54% | 5.11% | 3.90% | 3.15% | 5.46% | 5.25% |
Revenue per Share |
105.21 | 99.28 | 98.90 | 94.95 | 81.67 | 52.92 | 52.10 | 47.96 | 32.49 | 30.16 |
Operating CF per Share |
13.21 | 15.60 | 14.14 | 6.91 | 12.36 | 10.75 | 7.66 | 4.96 | 7.08 | 4.69 |
Capex per Share |
(2.22) | (2.04) | (1.71) | (1.74) | (1.40) | (0.77) | (0.94) | (0.89) | (0.83) | (0.77) |
Free Cash Flow per Share |
10.99 | 13.56 | 12.43 | 5.17 | 10.96 | 9.97 | 6.72 | 4.07 | 6.25 | 3.92 |
Cash per Share |
8.25 | 6.53 | 4.63 | 3.56 | 11.23 | 15.93 | 10.58 | 8.42 | 6.66 | 4.72 |
Shareholders Equity per Share |
117.23 | 114.46 | 112.55 | 104.23 | 120.20 | 35.00 | 30.78 | 25.02 | 22.00 | 17.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
117.23 | 114.46 | 112.55 | 104.23 | 120.20 | 35.00 | 30.78 | 25.02 | 22.00 | 17.11 |
Free Cash Flow |
861.99 | 1,118.59 | 1,020.34 | 421.16 | 735.39 | 527.15 | 361.90 | 220.24 | 338.37 | 216.60 |
Working Capital |
305.50 | 639.68 | 585.86 | 538.47 | 462.26 | 979.04 | 493.73 | 719.56 | 534.96 | 463.55 |
Capital Expenditures |
(174.21) | (168.06) | (140.69) | (142.16) | (93.75) | (40.88) | (50.64) | (48.40) | (44.72) | (42.60) |
Net Current Asset Value |
(3,574.72) | (3,918.30) | (4,337.65) | (5,458.25) | (6,379.06) | 517.61 | 375.03 | 330.21 | 145.40 | 77.29 |
EV/EBIT |
38.49 | 19.55 | 27.66 | 25.34 | 67.28 | 25.13 | 21.07 | 19.38 | 19.32 | 14.65 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
Price to Operating Income |
32.27 | 16.75 | 24.11 | 19.85 | 54.91 | 26.33 | 21.40 | 18.73 | 18.32 | 13.24 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.97 | 1.28 | 1.62 | 1.63 | 0.94 | 0.38 | 0.56 | 0.42 | 0.38 | 0.40 |
Cash ROIC |
6.51% | 8.34% | 7.62% | 3.13% | 5.16% | 17.20% | 13.64% | 10.20% | 17.81% | 13.94% |
Accounts Receivable Turnover |
5.14 | 4.68 | 4.28 | 4.70 | 4.92 | 4.09 | 5.27 | 5.69 | 3.88 | 3.57 |
Accounts Payable Turnover |
33.28 | 38.20 | 53.76 | 64.28 | 56.00 | 52.68 | 105.74 | 114.07 | 75.30 | 122.33 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
11.54 | 10.85 | 8.40 | 5.36 | 8.34 | 9.42 | 4.45 | 2.67 | 6.61 | 3.30 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1,604.12 | 1,751.57 | 1,895.60 | 1,646.83 | 1,114.31 | 684.77 | 532.73 | 456.19 | 453.60 | 466.29 |
Average Payables |
182.57 | 152.30 | 106.39 | 85.98 | 70.94 | 37.58 | 18.67 | 15.94 | 13.64 | 7.86 |
Average Assets |
16,452.30 | 16,812.34 | 17,087.57 | 17,286.19 | 10,411.35 | 3,171.56 | 2,630.88 | 2,250.44 | 1,986.23 | 1,771.53 |
Average Common Equity |
9,317.37 | 9,341.05 | 8,869.35 | 8,282.40 | 4,958.53 | 1,753.90 | 1,505.92 | 1,272.64 | 1,068.09 | 854.13 |
Columns are period end dates